XOM NYSE Week ended 24 Jul 2026

Weekly Investor Report

Exxon Mobil Corp · Energy · Oil & Gas Integrated

Latest close 156.9 USD
6.5% latest week
Weekly setup

Mixed setup

The weekly trend is not active. Price is 7.5% above the Trend Line and sits at 74.9% of its 52-week range. The latest completed week returned 6.5%, after a 14.9% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks weakly; valuation is neither clearly cheap nor expensive. Options positioning is mixed with 34/100 conviction, while the latest news-sentiment score is 51/100. Near-term considerations: volume confirmation is below normal; earnings are due in 1d.

Setup score 63 out of 100
Latest Close 156.9 USD 24 Jul 2026
1W Return 6.5% latest completed week
4W Return 14.9% short-term follow-through
12W Return 3.4% quarterly tape
Trend Breadth 88.5% 46 of 52 weeks active
Volume Ratio 0.8x vs 13-week average
What is working
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Next-week expectancy is positive at 56.10% based on similar historical setup states.
  • Latest weekly return ranks in the strongest part of its sector group.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Activity pressure is negative, which weakens the current setup.
  • Activity pressure is weak, so confirmation is not yet broad enough.
  • Recent volatility is running well above the one-year baseline.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is 7.5% above the Trend Line and sits at 74.9% of its 52-week range. The latest completed week returned 6.5%, after a 14.9% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.8x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.3612-week average 0.62

12-week confirmation

Trend active7/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership8/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.36Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 14.9% over four weeks, 3.4% over 12 weeks, and 46.7% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W6.5%
4W14.9%
12W3.4%
26W17.8%
52W46.7%
Active trend streak0 weeks
Active weeks in one year46
Trend breadth88.5%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-0.84Latest activity-pressure read.
Pressure change12.8%Four-week change in activity pressure.
Leadership10.75Latest relative-leadership reading.
RS change810.2%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks weakly; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Dec 2025 Field coverage 100% Model confidence 96%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength36/100Blend of value, momentum, and quality. Underlying universe rank 65; rank 1 is best.
Value33/100Relative valuation strength. Underlying universe rank 68; rank 1 is best.
Quality25/100Profitability and accounting quality. Underlying universe rank 76; rank 1 is best.
Momentum82/100Medium-term price momentum. Underlying universe rank 19; rank 1 is best.
Growth7/100Revenue and earnings growth. Underlying universe rank 94; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework31/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
25.7x
Price divided by trailing earnings.
Price / sales
2.0x
Market value relative to trailing revenue.
EV / EBITDA
11.5x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
11.0%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
25.5%
Gross profit retained from each unit of revenue.
Operating margin
10.2%
Operating profit retained from revenue.
Free-cash-flow margin
23.5%
Free cash flow generated from revenue.
Return on invested capital
8.1%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-4.1%
Latest one-year revenue growth.
EPS growth
-23.7%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-2.3%
Latest one-year free-cash-flow growth.
Piotroski F-score
3/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
2.6%
Cash dividends relative to market value.
Buyback yield
3.1%
Net share repurchases relative to market value.
Shareholder yield
5.7%
Dividend yield plus net buyback yield.
Net debt / EBITDA
0.6x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningMixed

XOM shows mixed options pressure with a 34/100 conviction score, put-call volume ratio of 0.78, expected move of 3.1%, and Sharemaestro trend signal inactive.

Conviction34/100
Expected move3.1%
Put/call volume0.78
Pressure17
Speculation41
Volatility44
Trend agreement53
Open options detail
Insider activity0 / 1

0 acquisitions and 1 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment51/100

Weighted news tone is neutral across 30 relevant articles.

8 positive · 19 neutral · 3 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings1dNext report is scheduled for 31 Jul 2026; event risk rises as the date approaches.
Options expected move3.1%Nearest-chain priced movement where available.
52-week drawdown-10.5%Distance below the 52-week high.
13-week volatility4.9%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher15 of 2611 weeks finished lower.
Best week+9.9%Week of 15 May.
Worst week-6.3%Week of 19 Jun.
Latest week+6.5%Week of 24 Jul.

Shape of recent returns

Strong gains6
Modest gains9
Flat weeks0
Modest losses6
Sharp losses5
Recent vol4.9%13-week weekly-return volatility.
Base vol3.6%52-week weekly-return volatility.
Up/down split32/20Count of positive and negative weeks in the 52-week window.
Average skew3.1% / -2.9%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 2026156.9 USD6.5%146.0 USD113.4 USD-0.8410.7567.0MOff
17 Jul 2026147.4 USD6.1%144.7 USD113.0 USD-1.103.8280.8MOff
10 Jul 2026138.9 USD1.3%143.6 USD112.6 USD-1.18-3.3870.7MOff
3 Jul 2026137.1 USD0.4%142.9 USD112.3 USD-1.06-3.2966.9MOff
26 Jun 2026136.5 USD-0.9%142.2 USD112.1 USD-0.96-1.5181.7MOff
19 Jun 2026137.8 USD-6.3%141.4 USD111.8 USD-0.93-2.83107.3MOn
12 Jun 2026147.0 USD-1.9%140.7 USD111.5 USD-0.864.5781.6MOn
5 Jun 2026149.9 USD3.2%139.7 USD111.2 USD-0.787.4070.0MOn
29 May 2026145.3 USD-6.2%138.5 USD110.8 USD-0.771.7971.3MOn
22 May 2026154.9 USD-1.9%137.4 USD110.5 USD-0.6810.3989.2MOn
15 May 2026157.9 USD9.9%136.0 USD110.1 USD-0.7013.9086.3MOn
8 May 2026143.6 USD-5.4%134.4 USD109.7 USD-0.664.1989.3MOn
1 May 2026151.8 USD2.6%133.3 USD109.4 USD-0.3012.7982.1MOn
24 Apr 2026147.9 USD1.7%131.9 USD109.1 USD0.2311.3274.3MOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.